DTL
ASMB icon

Dynamic Technology Lab’s Assembly Biosciences ASMB Stock Holding History

Dynamic Technology Lab’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,431
Closed -$79K – 1118
2021
Q1 		$79K Buy
+1,431
New +$94.8K 0.01% 1073

Other funds holding ASMB

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Dynamic Technology Lab's ASMB Position: Q2 2021 in Review

Dynamic Technology Lab sold out of Assembly Biosciences (ASMB) in Q2 2021, closing a stake of 1,431 shares — an estimated $79K sold.

Dynamic Technology Lab first reported a position in ASMB in Q1 2021 and held it in 1 quarter. The position peaked at $79K in Q1 2021. 91 funds tracked by Wall St. Rank hold ASMB as of Q2 2021.

  • Dynamic Technology Lab reported no remaining Assembly Biosciences position as of Q2 2021 after selling out during the quarter.
  • Dynamic Technology Lab sold 1,431 Assembly Biosciences shares in Q2 2021, an estimated $79K.
  • Dynamic Technology Lab first reported a position in Assembly Biosciences in Q1 2021 and held it in 1 quarter.
  • Dynamic Technology Lab's Assembly Biosciences position peaked at $79K in Q1 2021.
  • 91 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2021.

Based on Dynamic Technology Lab's 13F filing for Q2 2021, filed 13 Aug 2021.